Giardiasis is increasingly recognized as a systemic illness beyond its classical intestinal manifestations. This study aimed to characterize systemic manifestations across age groups by evaluating hematological, hepatic, and iron profiles. A retrospective cross-sectional analysis was conducted on 105 giardiasis cases in a tertiary center between 2022 and 2024, stratified by age. All infants exhibited reduction in packed cell volume, mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH); adolescents showed significant MCV reduction ( P = 0.018); young adults displayed reduced MCH ( P = 0.019). Elevated bilirubin is observed in children ( P = 0.025) and adolescents (P = 0.009). Most striking was iron metabolism dysregulation in 100% adults aged 18–60 years. The study also showed a male predominance (70.5%), with a seasonal peak during the monsoon period. These findings indicate that giardiasis causes age-specific systemic effects, with iron metabolism disruption in adults emerging as a key treatment focus.
Anand et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: